November 21, 2020, the Federal Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Regeneron Pharmaceuticals for its Regeneron infusion for COVID-19 treatment.
Read MoreCOVID-19: Treatment Billing Guide Regeneron EUA
Month: November 2020
Operator Insights: Revenue Recovery
Operator Insights is a Revenue Cycle Management thought leadership series from Ensemble Health Partners, who was voted Best In KLAS for healthcare revenue cycle outsourcing in 2020.
Read MoreCOVID-19: Treatment Billing Guide Bamlanivimab EUA
Under an executive order from President Trump, the Federal Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Eli Lilly for Bamlanivimab for the treatment of COVID-19.
Read MoreCincinnati Business Courier: Ensemble Still Hiring Hundreds During Pandemic
A fast-growing Greater Cincinnati health care company is looking to fill 250 local jobs – and more than 800 across the U.S. – as it continues to help its clients navigate the Covid-19 pandemic.
Read More